3 Thrombocytopenia Clinical Trials in Indianapolis, IN (2026)

Q: How do I join a clinical trial in Indianapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you.

Recruiting Thrombocytopenia Studies in Indianapolis

NCT06722235Recruiting

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it ...

Indianapolis, INPHASE3171 participantsTakeda

View Study Details

NCT06948318Recruiting

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a lower number of platelets, making i...

Indianapolis, INPHASE3150 participantsTakeda

View Study Details

NCT06533098Recruiting

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

The purpose of this study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT)....

Indianapolis, INPHASE350 participantsJanssen Research & Development, LLC

View Study Details

About Thrombocytopenia Clinical Trials in Indianapolis

Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.

There are currently 3 thrombocytopenia clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 371 participants. Research is being sponsored by Takeda, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Thrombocytopenia Clinical Trials in Indianapolis — FAQ

Are there thrombocytopenia clinical trials in Indianapolis?

Yes, there are 3 thrombocytopenia clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What thrombocytopenia treatments are being tested?

The 3 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.

Data updated October 15, 2026 from ClinicalTrials.gov